Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6194)
All Articles published online
|
Publishing Process of This Article
|
Sep 15, 2021 (publication date) through Nov 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Khandelwal R, Dassanayake AS, Conjeevaram HS, Singh SP. Non-alcoholic fatty liver disease in diabetes: When to refer to the hepatologist? World J Diabetes 2021; 12(9): 1479-1493 [PMID: 34630901 DOI: 10.4239/wjd.v12.i9.1479] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i9/1479.htm |
| Number | Citing Articles |
| 1 |
Xiao Lei, Emi Ishida, Satoshi Yoshino, Shunichi Matsumoto, Kazuhiko Horiguchi, Eijiro Yamada. Calorie Restriction Using High-Fat/Low-Carbohydrate Diet Suppresses Liver Fat Accumulation and Pancreatic Beta-Cell Dedifferentiation in Obese Diabetic Mice. Nutrients 2024; 16(7): 995 doi: 10.3390/nu16070995
|
| 2 |
Ariel Jaffe, Tamar H. Taddei, Edoardo G. Giannini, Ysabel C. Ilagan‐Ying, Massimo Colombo, Mario Strazzabosco. Holistic management of hepatocellular carcinoma: The hepatologist's comprehensive playbook. Liver International 2022; 42(12): 2607 doi: 10.1111/liv.15432
|
| 3 |
J. Fu, Z. Mu, L. Sun, X. Gao, X. Hu, S. Xiu. Chinese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease have lower serum osteocalcin levels compared to individuals with type 2 diabetes mellitus and no liver disease: a single-center cross-sectional study. Journal of Endocrinological Investigation 2022; 45(12): 2275 doi: 10.1007/s40618-022-01861-z
|
| 4 |
Chun-Sik Bae, Youngchan Lee, Taeho Ahn. Therapeutic treatments for diabetes mellitus-induced liver injury by regulating oxidative stress and inflammation. Applied Microscopy 2023; 53(1) doi: 10.1186/s42649-023-00089-2
|
| 5 |
Tanawan Kongmalai, Varalak Srinonprasert, Thunyarat Anothaisintawee, Pinkawas Kongmalai, Gareth McKay, John Attia, Ammarin Thakkinstian. New anti-diabetic agents for the treatment of non-alcoholic fatty liver disease: a systematic review and network meta-analysis of randomized controlled trials. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1182037
|
| 6 |
Ioanna Papagiouvanni, Marieta P. Theodorakopoulou, Pantelis A. Sarafidis, Emmanouil Sinakos, Ioannis Goulis. Peripheral endothelial and microvascular damage in liver cirrhosis: A systematic review and meta‐analysis. Microcirculation 2022; 29(4-5) doi: 10.1111/micc.12773
|
| 7 |
D. Mounika Mellemputi, Hemanth Harish. Assessment of Non-Alcoholic Fatty Liver Disease as Risk Factor for Cardiovascular Disease. Indian Journal of Cardiovascular Disease in Women 2023; 8: 230 doi: 10.25259/IJCDW_23_2022
|
| 8 |
Donna R Cryer. The Global Liver Institute "Liver Health is Public Health" Initiative. European Endocrinology 2023; 19(2): 3 doi: 10.17925/EE.2023.19.2.3
|
| 9 |
Zhihua Ren, Samuel Kumi Okyere, Lei Xie, Juan Wen, Jiayi Wang, Zhengli Chen, Xueqin Ni, Junliang Deng, Yanchun Hu. Oral Administration of Bacillus toyonensis Strain SAU-20 Improves Insulin Resistance and Ameliorates Hepatic Steatosis in Type 2 Diabetic Mice. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.837237
|
| 10 |
Irene Caruso, Nicola Marrano, Giuseppina Biondi, Valentina Annamaria Genchi, Rossella D'Oria, Gian Pio Sorice, Sebastio Perrini, Angelo Cignarelli, Annalisa Natalicchio, Luigi Laviola, Francesco Giorgino. Glucagon in type 2 diabetes: Friend or foe?. Diabetes/Metabolism Research and Reviews 2023; 39(3) doi: 10.1002/dmrr.3609
|
| 11 |
Guo-heng Zhang, Tian-hao Yuan, Zhen-sheng Yue, Lin Wang, Guo-Rui Dou. The presence of diabetic retinopathy closely associated with the progression of non-alcoholic fatty liver disease: A meta-analysis of observational studies. Frontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.1019899
|
| 12 |
Yusuf Aksu, Ali Ugur Uslu, Gulten Tarhan, Şaban Tiryaki. Renal Artery Resistive Index and Estimated Glomerular Filtration Rate in Patients with Non-alcoholic Fatty Liver Disease. Current Medical Imaging Reviews 2022; 18(12): 1318 doi: 10.2174/1573405618666220516123519
|
| 13 |
Zobair M. Younossi, Linda Henry. Epidemiology of NAFLD – Focus on diabetes. Diabetes Research and Clinical Practice 2024; 210: 111648 doi: 10.1016/j.diabres.2024.111648
|
| 14 |
Md Asrarul Islam, Rhema Khairnar, Joshua Fleishman, Sandra E. Reznik, Louis Ragolia, Shruthi Gobbooru, Sunil Kumar. Female C57BL/6 mice exhibit protection against nonalcoholic fatty liver disease and diabesity accompanied by differential regulation of hepatic lipocalin prostaglandin D2 synthase. Molecular and Cellular Endocrinology 2025; 595: 112404 doi: 10.1016/j.mce.2024.112404
|
| 15 |
Ehsan Amini-Salehi, Soheil Hassanipour, Mohammad-Hossein Keivanlou, Milad Shahdkar, Mahdi Orang Goorabzarmakhi, Azin Vakilpour, Farahnaz Joukar, Mohammad Hashemi, Nazila Sattari, Mohammadreza Javid, Fariborz Mansour-Ghanaei. The impact of gut microbiome-targeted therapy on liver enzymes in patients with nonalcoholic fatty liver disease: an umbrella meta-analysis. Nutrition Reviews 2024; 82(6): 815 doi: 10.1093/nutrit/nuad086
|
| 16 |
Nahla E. El-Ashmawy, Eman G. Khedr, Ghada M. Al-Ashmawy, Asmaa A. Kamel. Emerging role of natural lipophagy modulators in metabolic dysfunction–associated steatotic liver disease. Nutrition 2024; 126: 112517 doi: 10.1016/j.nut.2024.112517
|